Adamis Pharmaceuticals Corp - FORM 10-K - EX-23.2 - CONSENT OF MAYER HOFFMAN MCCANN P.C. - April 15, 2021

Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadmp-10k_123120.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex32-2.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex32-1.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex31-2.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex31-1.htm
EX-23.1 - CONSENT OF BDO USA, LLP - Adamis Pharmaceuticals Corpex23-1.htm
EX-21.1 - SUBSIDIARIES - Adamis Pharmaceuticals Corpex21-1.htm
EX-10.73 - PROMISSORY NOTE DATED MARCH 15, 2021 - Adamis Pharmaceuticals Corpex10-73.htm
EX-10.72 - LEASE AGREEMENT - Adamis Pharmaceuticals Corpex10-72.htm
EX-10.20 - FIRST AMENDMENT TO LEASE - Adamis Pharmaceuticals Corpex10-20.htm
EX-4.6 - DESCRIPTION OF CAPITAL STOCK - Adamis Pharmaceuticals Corpex4-6.htm
 

Adamis Pharmaceuticals Corporation 10-K

  

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-159229, 333-169106, 333-175383, 333-194635, 333-201742, 333-211773, 333-218945, 333-226230, and 333-229379), and Form S-3 (Nos. 333-196976, 333-199454, 333-200447, 333-209401, 333-212880, 333-217400, 333-217408, 333-226100 and 333-249331) of our report dated March 30, 2020, except as it relates to Note 22, as to which the date is October 5, 2020 (which includes an explanatory paragraph related to the existence of substantial doubt about the Company’s ability to continue as a going concern) relating to the consolidated financial statements of Adamis Pharmaceuticals Corporation and Subsidiaries (the Company), as of and for the year ended December 31, 2019, included in this Annual Report on Form 10-K as of December 31, 2020.

 

 

 

 

/s/ Mayer Hoffman McCann P.C.

 

San Diego, California

April 15, 2021

  

 

 

   

 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports